Not necessarily, Rybelsus is branded and regulated / script-only / expensive. I mean Sema but pretty much any peptide, as the study mentions, could be made orally available by formulating it with absorption enhancer sodium N-(8-[2-hydroxybenzoyl] amino) caprylate.
Now in central Europe to get Rybelsus / Saxenda / Ozempic prescribed is incredibly difficult, and the co-pay is ridiculously expensive. I, myself, am fine with injectables, but I have elderly parents, and they would benefit from oral forms of some peptides.
And I imagine plenty of folks would get on Sema / Tirzepatide train for their weight-loss goals if there wasn't the need for injections. Ask any diabetic, nobody likes to prick themselves.
Now, the added costs associated with that are a factor for sure. The question is how much extra would that be, considering the potential market for such a product could be substantial, outside the body-building community.
Just food for thought.
@
Qingdao Sigma Chemicals thanks for the answer, makes total sense. I'll stick to injectables for the time being!